Literature DB >> 26408197

Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.

Sharad K Mittal1, Kyung-Jin Cho1, Satoshi Ishido2, Paul A Roche3.   

Abstract

Efficient immune responses require regulated antigen presentation to CD4 T cells. IL-10 inhibits the ability of dendritic cells (DCs) and macrophages to stimulate antigen-specific CD4 T cells; however, the mechanisms by which IL-10 suppresses antigen presentation remain poorly understood. We now report that IL-10 stimulates expression of the E3 ubiquitin ligase March-I in activated macrophages, thereby down-regulating MHC-II, CD86, and antigen presentation to CD4 T cells. By contrast, IL-10 does not stimulate March-I expression in DCs, does not suppress MHC-II or CD86 expression on either resting or activated DCs, and does not affect antigen presentation by activated DCs. IL-10 does, however, inhibit the process of DC activation itself, thereby reducing the efficiency of antigen presentation in a March-I-independent manner. Thus, IL-10 suppression of antigen presenting cell function in macrophages is March-I-dependent, whereas in DCs, suppression is March- I-independent.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  antigen presentation; dendritic cell; immunosuppression; interleukin; macrophage; major histocompatibility complex (MHC); ubiquitin ligase

Mesh:

Substances:

Year:  2015        PMID: 26408197      PMCID: PMC4646393          DOI: 10.1074/jbc.M115.682708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Cloning and functional characterization of the 5'-regulatory region of the human CD86 gene.

Authors:  J Li; A I Colovai; R Cortesini; N Suciu-Foca
Journal:  Hum Immunol       Date:  2000-05       Impact factor: 2.850

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo.

Authors:  Claus Haase; Trine N Jørgensen; Birgitte K Michelsen
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 4.  Antigen presentation to naive CD4 T cells in the lymph node.

Authors:  Andrea A Itano; Marc K Jenkins
Journal:  Nat Immunol       Date:  2003-08       Impact factor: 25.606

5.  Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.

Authors:  D Pajkrt; L Camoglio; M C Tiel-van Buul; K de Bruin; D L Cutler; M B Affrime; G Rikken; T van der Poll; J W ten Cate; S J van Deventer
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

6.  Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling.

Authors:  B Koppelman; J J Neefjes; J E de Vries; R de Waal Malefyt
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

7.  Suppressed expression of surface Ia on macrophages by lipopolysaccharide: evidence for regulation at the level of accumulation of mRNA.

Authors:  T J Koerner; T A Hamilton; D O Adams
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

8.  Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.

Authors:  Yaozhong Ding; Dongmei Chen; Adel Tarcsafalvi; Ruthie Su; Lihui Qin; Jonathan S Bromberg
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 9.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  48 in total

Review 1.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

2.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

3.  A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene.

Authors:  Sunil Kaul; Sharad K Mittal; Paul A Roche
Journal:  J Biol Chem       Date:  2018-01-29       Impact factor: 5.157

4.  Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease.

Authors:  Rohan Bir Singh; Tomas Blanco; Sharad K Mittal; Yukako Taketani; Sunil K Chauhan; Yihe Chen; Reza Dana
Journal:  Ocul Surf       Date:  2020-05-06       Impact factor: 5.033

5.  Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.

Authors:  Amélie Vromman; Victoria Ruvkun; Eugenia Shvartz; Gregory Wojtkiewicz; Gustavo Santos Masson; Yevgenia Tesmenitsky; Eduardo Folco; Hermann Gram; Matthias Nahrendorf; Filip K Swirski; Galina K Sukhova; Peter Libby
Journal:  Eur Heart J       Date:  2019-08-07       Impact factor: 29.983

6.  Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1β - induced anxiety and sickness behaviors in adult male rats.

Authors:  Soumyabrata Munshi; Victoria Parrilli; J Amiel Rosenkranz
Journal:  Behav Brain Res       Date:  2019-06-10       Impact factor: 3.332

7.  Serum cytokine profile as a potential prognostic tool in colorectal cancer patients - one center study.

Authors:  Paulina Czajka-Francuz; Tomasz Francuz; Sylwia Cisoń-Jurek; Aleksander Czajka; Marcin Fajkis; Bożena Szymczak; Maciej Kozaczka; Krzysztof Piotr Malinowski; Wojciech Zasada; Jerzy Wojnar; Jerzy Chudek
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-21

Review 8.  Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.

Authors:  Lin Tian; Anhua Lei; Tianyu Tan; Mengmeng Zhu; Li Zhang; Haibo Mou; Jin Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-09-28

9.  Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I.

Authors:  Lei Lei; Joanna Bandola-Simon; Paul A Roche
Journal:  J Biol Chem       Date:  2018-02-01       Impact factor: 5.157

10.  The Innate Lymphoid System Is a Critical Player in the Manifestation of Mucoinflammatory Airway Disease in Mice.

Authors:  Brandon W Lewis; Ishita Choudhary; Kshitiz Paudel; Yun Mao; Rahul Sharma; Yong Wang; Jessy S Deshane; Richard C Boucher; Sonika Patial; Yogesh Saini
Journal:  J Immunol       Date:  2020-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.